Skip to main content

CombiMatrix and Cyrano Sciences to Co-Develop Chemical Sensors

NEW YORK, Jan. 12 (GenomeWeb News) - Acacia Research said today that its CombiMatrix microarray subsidiary will collaborate with Cyrano Sciences to develop chemical sensors that use both companies' technologies.


CombiMatrix, based in Mulkiteo, Wash., will contribute its microarray technology and Cyrano, located in Pasadena, Calif., its nanocomposite sensor or "electronic nose" technology to develop biochips for sensing chemical agents in air and water.


Up until now, CombiMatrix has developed its array technology for applications in genetic analysis, RNAi drug discovery, biodefense applications, and nanomaterials discovery.


The Scan

Pfizer-BioNTech Seek Full Vaccine Approval

According to the New York Times, Pfizer and BioNTech are seeking full US Food and Drug Administration approval for their SARS-CoV-2 vaccine.

Viral Integration Study Critiqued

Science writes that a paper reporting that SARS-CoV-2 can occasionally integrate into the host genome is drawing criticism.

Giraffe Species Debate

The Scientist reports that a new analysis aiming to end the discussion of how many giraffe species there are has only continued it.

Science Papers Examine Factors Shaping SARS-CoV-2 Spread, Give Insight Into Bacterial Evolution

In Science this week: genomic analysis points to role of human behavior in SARS-CoV-2 spread, and more.